Yasushi Sakata

Research interests

Publications

• The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

  Nature Medicine · 2022 · https://doi.org/10.1038/s41591-021-01659-1

• Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure

  European Journal of Heart Failure · 2021 · https://doi.org/10.1002/ejhf.2115

• Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases

  Nature Genetics · 2020 · https://doi.org/10.1038/s41588-020-0640-3

• Population-specific and trans-ancestry genome-wide analyses identify distinct and shared genetic risk loci for coronary artery disease

  Nature Genetics · 2020 · https://doi.org/10.1038/s41588-020-0705-3

• JCS 2017/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure ― Digest Version ―

  Circulation Journal · 2019 · https://doi.org/10.1253/circj.cj-19-0342

• JCS 2016 Guideline on Diagnosis and Treatment of Cardiac Sarcoidosis ― Digest Version ―

  Circulation Journal · 2019 · https://doi.org/10.1253/circj.cj-19-0508

• Bcl-2-like protein 13 is a mammalian Atg32 homologue that mediates mitophagy and mitochondrial fragmentation

  Nature Communications · 2015 · https://doi.org/10.1038/ncomms8527

• Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension

  Proceedings of the National Academy of Sciences · 2015 · https://doi.org/10.1073/pnas.1424774112

Current projects

No projects listed.